Literature DB >> 16914709

The treatment triangle for staphylococcal infections.

M Lindsay Grayson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16914709     DOI: 10.1056/NEJMe068152

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  12 in total

1.  Intra- and extracellular activities of dicloxacillin and linezolid against a clinical Staphylococcus aureus strain with a small-colony-variant phenotype in an in vitro model of THP-1 macrophages and an in vivo mouse peritonitis model.

Authors:  Anne Sandberg; Sandrine Lemaire; Françoise Van Bambeke; Paul M Tulkens; Diarmaid Hughes; Christof von Eiff; Niels Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2011-01-31       Impact factor: 5.191

2.  Intra- and extracellular activities of dicloxacillin against Staphylococcus aureus in vivo and in vitro.

Authors:  Anne Sandberg; Klaus Skovbo Jensen; Pierre Baudoux; Françoise Van Bambeke; Paul M Tulkens; Niels Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

Review 3.  Predictors of mortality in Staphylococcus aureus Bacteremia.

Authors:  Sebastian J van Hal; Slade O Jensen; Vikram L Vaska; Björn A Espedido; David L Paterson; Iain B Gosbell
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

4.  Molecular characterization of Staphylococcus aureus isolates from a 2005 clinical trial of uncomplicated skin and skin structure infections.

Authors:  Ronald N Jones; Angela M Nilius; Bolanle K Akinlade; Lalitagauri M Deshpande; Gerard F Notario
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

5.  Tetracyclines as an oral treatment option for patients with community onset skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus.

Authors:  Jörg J Ruhe; Anupama Menon
Journal:  Antimicrob Agents Chemother       Date:  2007-06-18       Impact factor: 5.191

6.  In vitro activity of daptomycin against Staphylococci isolated from bacteremia and community-onset skin and soft tissue infections in France: data from two nationwide studies.

Authors:  O Gallon; C Guillet-Caruba; B Lamy; F Laurent; F Doucet-Populaire; J-W Decousser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-06-06       Impact factor: 3.267

7.  Intracellular activity of antibiotics against Staphylococcus aureus in a mouse peritonitis model.

Authors:  Anne Sandberg; Jonas H R Hessler; Robert L Skov; Jens Blom; Niels Frimodt-Møller
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

Review 8.  Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia.

Authors:  Philip I Hair; Susan J Keam
Journal:  Drugs       Date:  2007       Impact factor: 9.546

9.  Ceftaroline in complicated skin and skin-structure infections.

Authors:  Paul O Hernandez; Sergio Lema; Stephen K Tyring; Natalia Mendoza
Journal:  Infect Drug Resist       Date:  2012-01-19       Impact factor: 4.003

10.  Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care.

Authors:  Linda F McCaig; L Clifford McDonald; Sanjay Mandal; Daniel B Jernigan
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.